Staff Location: Directors

Stoyan Radkov, PhD

After a successful career as a senior scientist at Imperial College London and University College London, researching viral oncology, Stoyan trained as a patent attorney at the top tier IP firm D. Young & Co, before moving in-house to Pfizer, in the UK, and then Novartis and Syngenta, in Switzerland.

Stoyan has a wealth of experience in undertaking patent due diligence projects, FTOs, validity & infringement opinions, IP landscape analyses, patent application drafting and filing, global patent prosecution, life-cycle management and strategic advice.  Stoyan advises companies on the value of their existing IP portfolio and how to maximize its full potential.

One of Stoyan’s particular strengths is his ability to rapidly grasp technically & scientifically demanding concepts. Stoyan is also able to explain complex technical and scientific concepts clearly and succinctly to others – especially to members of the EPO.

 His success at the EPO has been recognized in the Legal 500: “New partner Stoyan Radkov specializes in high-value oppositions and appeals at the EPO, representing clients from the biotech and life sciences industries.”  Stoyan’s education and training include the following:

  • First Class – BSc Honours Degree – Microbiology, University of Reading
  • PhD – Viral Oncology – Ludwig Institute for Cancer Research, St Mary’s Hospital, Imperial College London
  • Post-doctoral fellow – Imperial College London
  • Senior CRC funded post-doctoral fellow – University College London
  • Private practice IP attorney – D. Young & Co (UK), UDL (Partner – UK) and HGF (Director, UK and Basel, CH)
  • In-house IP attorney – Pfizer (Sandwich, UK), Novartis (Basel, CH) and Syngenta (Basel, CH)

Tarik Nabi

Tarik M. Nabi, Ph.D., JD, has a background in scientific research and is a patent attorney having experience with numerous technologies, including chemical engineering, electrochemistry, materials science, semiconductor manufacturing, image processing, medical devices, pharmaceuticals, computer software, and telecommunications.  He has lectured and supervised training seminars for technology companies and law firms, U.S. and foreign, on various aspects of patent practice.

After spending a career in private practice as a patent attorney, Tarik now specializes in consulting early, mid-stage, and mature technology companies to enhance their valuations and monetize IP portfolios by determining white spaces and charting IP policy to exploit them.

Tarik graduated with a Ph.D. in Electrochemistry from the George Washington University in 1999, and received his law degree from The George Mason University School of Law in 2008. He is admitted to practice in Virginia, the District of Columbia, and the U.S. Patent & Trademark Office.

Tarik is fluent in French, frequently travels to France and other European countries, and is also a member of the French-American Chamber of Commerce.